COVID-19 vaccines: New candidates & answers to commonly asked questions
The Journal of Family Practice. 2021 March;70(2):audio
February 22, 2021|The Journal of Family Practice
Author and Disclosure Information
Which patients should not get the COVID-19 vaccine because of the risk of anaphylaxis? Can the COVID-19 vaccine be co-administered with other vaccines? Is there flexibility in the timing of the 2-dose regimen for COVID-19 vaccine? Dr. Campos-Outcalt answers these common questions and more. He also describes the newest vaccine candidate to be approved (and the advantages it may offer), and previews a fourth option that’s in the pipeline.
REFERENCES
- CDC. COVID-19 vaccination. Accessed February 22, 2021.
- CDC. COVID data tracker. Accessed February 22, 2021.
- Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1922-1924. Accessed February 22, 2021.
- Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2021;69:1653-1656. Accessed February 22, 2021.
- Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morbid Mortal Wkly Rep. ePub: February 19, 2021. Accessed February 22, 2021.
- CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:125-129. Accessed February 25, 2021.